Selective induction of MCP-1 in human mesangial cells by the IL-6/sIL-6R complex

被引:1
|
作者
Coletta, I
Soldo, L
Polentarutti, N
Mancini, F
Guglielmotti, A
Pinza, M
Mantovani, A
Milanese, C
机构
[1] ACRAF SPA, Angelini Ric, I-00040 Monte Porzio Catone, Italy
[2] Ist Ric Farmacol Mario Negri, Milan, Italy
来源
EXPERIMENTAL NEPHROLOGY | 2000年 / 8卷 / 01期
关键词
MCP-1; chemokines; mesangial cells; interleukin; 6; receptor;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Interleukin (IL) 6, an autocrine growth factor for mesangial cells, and chemokines, which are released from activated mesangial cells and induce leukocyte infiltration, play a critical role in the progression of immune system mediated renal diseases. Since the reciprocal relationship between IL-6 and chemokines in renal inflammation has been barely investigated, we have analyzed whether IL-6 (500 ng/ml), alone or in combination with the soluble form of its receptor (sIL-6R, 200 ng/ml), can induce normal human mesangial cells (NHMC) to release alpha and/or beta chemokines: MCP-1 (monocyte chemoattractant protein 1), IL-8, Rantes (regulated on activation, normal T cell expressed and secreted), and MIP-1 alpha (macrophage inflammatory protein 1 alpha). Whereas IL-6 or sIL-6R alone were ineffective in inducing significant chemokine release from NHMC, the simultaneous treatment with IL-6 and sIL-6R showed a significant interaction, leading to a strong synergic effect on MCP-1 synthesis and release without exerting any relevant activity on IL-8, Rantes, or MIP-1 alpha. Consistently with the unresponsiveness to IL-6, mRNA and protein expression analysis of the two sub-units which form the functional IL-6 receptor showed that NHMC express only the gp130 signal-transducing chain and not the subunit-specific IL-6R (gp80). These findings support an unexpected role of the IL-6 system in kidney inflammatory reactions through the selective regulation of monocyte recruitment. Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:37 / 43
页数:7
相关论文
共 50 条
  • [1] Human myoblasts secrete MCP-1 and IL-6 and express ICAM-1 in response to IL-6/sIL-6R complex in vitro
    Marino, M.
    Scuderi, F.
    Provenzano, C.
    Schellet, Juergen
    Rose-John, Stefan
    Bartoccioni, Emanuela
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 178 : 96 - 96
  • [2] Interleukin-6 (IL-6)/soluble interleukin-6 receptor (sIL-6R) complex, but not IL-6 or sIL-6R alone, inhibits myocardial apoptosis
    Matsushita, K
    Iwanaga, S
    Oda, T
    Kimura, K
    Shimada, M
    Tanaka, M
    Matsumura, S
    CIRCULATION, 2002, 106 (19) : 306 - 306
  • [3] IL-6, sIL-6R/IL-6 complex and insulin-resistance in obese children
    De Filippo, Gianpaolo
    Rendina, Domenico
    Campanozzi, Angelo
    Moccia, Filomena
    Rocco, Vincenzo
    Mossetti, Giuseppe
    Melone, Maria Rita
    Spinosa, Enrico
    Mantovani, Massimo Pettoello
    HORMONE RESEARCH, 2006, 65 : 51 - 51
  • [4] The IL-6/sIL-6R complex as a novel target for therapeutic approaches
    Rose-John, Stefan
    Waetzig, Georg H.
    Scheller, Juergen
    Groetzinger, Joachim
    Seegert, Dirk
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2007, 11 (05) : 613 - 624
  • [5] CIRCULATING SOLUBLE IL-6 RECEPTOR (SIL-6R) AND IL-6/SIL-6R COMPLEX IN PATIENTS WITH SYSTEMIC-ONSET JUVENILE RHEUMATOID-ARTHRITIS (SOJRA)
    DEBENEDETTI, F
    PIGNATTI, P
    MASSA, M
    ALBANI, S
    RAMENGHI, B
    NOVICK, D
    MARTINI, A
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S60 - S60
  • [6] Impairment of gingival fibroblast adherence by IL-6/sIL-6R
    Naruishi, K
    Takashiba, S
    Nishimura, F
    Chou, HH
    Arai, H
    Yamada, H
    Murayama, Y
    JOURNAL OF DENTAL RESEARCH, 2001, 80 (05) : 1421 - 1424
  • [7] Circulating IL-6 and sIL-6R in patients with hepatocellular carcinoma
    Giannitrapani, L
    Cervello, M
    Soresi, M
    Notarbartolo, M
    La Rosa, M
    Virruso, L
    D'Alessandro, N
    Montalto, G
    HORMONE-RELATED TUMORS: NOVEL APPROACHES TO PREVENTION AND TREATMENT, 2002, 963 : 46 - 52
  • [8] The balance of interleukin (IL)-6, IL-6•soluble IL-6 receptor (sIL-6R), and IL-6•sIL-6R•sgp130 complexes allows simultaneous classic and trans-signaling
    Baran, Paul
    Hansen, Selina
    Waetzig, Georg H.
    Akbarzadeh, Mohammad
    Lamertz, Larissa
    Huber, Heinrich J.
    Ahmadian, M. Reza
    Moll, Jens M.
    Scheller, Juergen
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (18) : 6762 - 6775
  • [9] The effect of IL-6 and sIL-6R on the expression of cartilage matrix proteins
    Namba, A.
    Aida, Y.
    Watanabe, Y.
    Tanaka, H.
    Shimizu, O.
    Suzuki, N.
    Maeno, M.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S266 - S266
  • [10] HUMAN SOLUBLE INTERLEUKIN-6 RECEPTOR (SIL-6R) FROM MYELOMA CELLS POTENTIATES IL-6 ACTIVITY
    LUST, JA
    JELINEK, DF
    FREDERICK, LA
    HUNTLEY, BK
    BRAATEN, JK
    MAIHLE, NJ
    BLOOD, 1993, 82 (10) : A200 - A200